Author

Nicoletta Protti

University of PaviaORCID 0000-0002-2415-128XUnclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1

Frequent Co-Authors

Agata Jakóbik‐KoloniD· 1 shared Alessandro Somenzi· 1 shared Barbara NawrotiD· 1 shared Damian KaniowskiiD· 1 shared Dongfang WangiD· 1 shared Elaine Y. KangiD· 1 shared Jeremy HalliD· 1 shared Justyna SuwaraiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBiochemistry

Agata Jakóbik‐KolonORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

BiochemistrybioRxivPreprintAug 7, 2025

EGFR-targeted antisense oligonucleotides modified with boron clusters offer an innovative approach to cancer chemo-radiotherapy

Damian Kaniowski, Katarzyna Ebenryter‐Olbińska, Justyna Suwara…·Barbara Nawrot

This paper demonstrates that B-ASOLNA-CHOL, a boron cluster-conjugated antisense oligonucleotide, enhances cancer cell uptake and cytotoxicity when combined with radiotherapy, reducing tumor size in xenograft models.

1 citation

humanexperimental assay

𝕏 PostBluesky